Skip to content
NBDC Human Database

No datasets in the cart.

Due to system maintenance, the application system, application review by the Data Access Committee will be unavailable during the following period.
Schedule: October 5th (Mon), 2026, 9:00 - October 7th (Wed), 2026, 15:00 (JST)
We apologize for any inconvenience this may cause and appreciate your understanding.

We are currently receiving a large number of applications for data submission, and the review process is taking longer than usual.We sincerely apologize for the delay and kindly ask for your understanding. When submitting an application, we would greatly appreciate it if you could allow sufficient time for the processing.

Following a change to our organizational structure effective April 1, 2026, this division has been renamed from the "Database Center for Life Science, Joint Support-Center for Data Science Research" to the "Database Division for Life Science (DBCLS), BioData Science Initiative (BSI), National Institute of Genetics (NIG)". Where the former name still appears in the guidelines, please read it as the new name.

Research ID

hum0005-v3Release info

This page is a past version (v3). The latest version is v8.
Latest version (v8)

Research title

Genetic Analysis of Hearing Loss and Its Clinical Application

Research overview

Aims
To identify the causative gene mutation of hearing impairment including non-syndromic hearing loss, syndromic hearing loss, and inner, middle, outer ear malformation.
Methods
Massively Parallel DNA Sequencing was performed with an Ion Torrent Personal Genome Machine (PGM), Ion Proton or Ion S5 system using the Ion PGM 200, Proton HiQ Sequencing Kit and Ion 318 Chip or Ion P1 chip (Thermo Fisher Scientific) or 540 chip chef kit (S5) or HiSeq 2000 system (Illumina).
Participants/materials
Usher Syndrome: 17 patients
Non-usher syndrome: 39 patients (Controlled-access) + 5 patients (Unrestricted-access) + 19 patients (Controlled-access) + 19 patients (Controlled-access) + 39 patients (Controlled-access) + 1 patient (Controlled-access) + 28 patients (Controlled-access) + 7 patient (Controlled-access) + 26 patients (Controlled-access) + 15 patients (Controlled-access) + 2969 patients (Controlled-access)
URL
N/A

Datasets

The list is the one this version published; each dataset's content is shown as it is now.

CartDataset IDType of dataAnalysis methodAccess criteriaDate published
DRA001273NGS (Target Capture: Nine genes)
  • Targeted DNA sequencing
Unrestricted-access2014-01-06
JGAD000032NGS (Target Capture)
  • Targeted DNA sequencing
Controlled-access (Type I)2020-09-28
JGAD000093NGS (Target Capture)
  • Targeted DNA sequencing
Controlled-access (Type I)2020-09-28
DRA003791NGS (Target Capture)
  • Targeted DNA sequencing
Unrestricted-access2015-10-01

Data provider

Principal investigator
Shin-ichi Usami
Affiliation
Department of Hearing Implant Sciences, Shinshu University School of Medicine

Research projects

No research projects.

Grants

NameTitleProject number
Practical Research Project for Rare / Intractable Diseases, Japan Agency for Medical Research and Development
Development of evidence based treatments for inherited hearing loss
  • JP16ek0109114
Program for an Integrated Database of Clinical and Genomic Information, Japan Agency for Medical Research and Development
Development of unified data storage (DS) of clinical and genomic information for sensory disorders
  • JP16kk0205010
Practical Research Project for Rare / Intractable Diseases, Japan Agency for Medical Research and Development
Development of evidence based clinical management for hereditary hearing loss.
  • JP18ek0109363
Health and Labour Sciences Research Grant for Comprehensive Research on Disability Health and Welfare
Research and Survey for Intractable Hearing Loss
  • 20FC1048
Research and Development Grants for Comprehensive Research for Persons with Disabilities, Japan Agency for Medical Research and Development
Research on building a treatment and rehabilitation system for childhood hearing loss based on causal diagnosis.
  • JP16dk0310067
Practical Research Project for Rare / Intractable Diseases, Japan Agency for Medical Research and Development
Development of evidence based clinical management for syndromic hearing loss.
  • JP21ek0109542
Health and Labour Sciences Research Grant for Research on Rare and Intractable Diseases
Research and Survey for Usher syndrome
  • H22-難治-一般-058
Health and Labour Sciences Research Grant for Research on Rare and Intractable Diseases
Research and Survey for Inherited Hearing Loss and Inner-, Middle- and Outer Ear Malfolmation
  • H24-難治(難)-一般-032
Health and Labour Sciences Research Grant for Comprehensive Research on Disability Health and Welfare
Development and Clinical Application of NGS Based Genetic Testing for Deafness
  • H25-感覚-一般-002
Health and Labour Sciences Research Grant for Comprehensive Research on Disability Health and Welfare
Research and Survey for Intractable Hearing Loss
  • H26-難治等(難)-一般-032
Health and Labour Sciences Research Grant for Comprehensive Research on Disability Health and Welfare
Research and Survey for Intractable Hearing Loss
  • H29-難治等(難)-一般-031

Related publications

TitleDOIDataset ID
Massively parallel DNA sequencing facilitates diagnosis of patients with Usher syndrome type 1.
An effective screening strategy for deafness in combination with a next-generation sequencing platform: a consecutive analysis.
Frequency of Usher syndrome type 1 in deaf children by massively parallel DNA sequencing.
POU4F3 mutation screening in Japanese hearing loss patients: Massively parallel DNA sequencing-based analysis identified novel variants associated with autosomal dominant hearing loss
WFS1 mutation screening in a large series of Japanese hearing loss patients: Massively parallel DNA sequencing-based analysis.
OTOF mutation analysis with massively parallel DNA sequencing in 2,265 Japanese sensorineural hearing loss patients.
Detailed Clinical Features of Deafness Caused by a Claudin-14 Variant.
Mutational Spectrum and Clinical Features of Patients with LOXHD1 Variants Identified in an 8074 Hearing Loss Patient Cohort.
Mid-Frequency Hearing Loss Is Characteristic Clinical Feature of OTOA-Associated Hearing Loss.
The Prevalence and Clinical Characteristics of TECTA-Associated Autosomal Dominant Hearing Loss.
Prevalence and Clinical Characteristics of Hearing Loss Caused by MYH14 Variants.
Simple and efficient germline copy number variant visualization method for the Ion AmpliSeq™ custom panel.
The Clinical Next-Generation Sequencing Database: A Tool for the Unified Management of Clinical Information and Genetic Variants to Accelerate Variant Pathogenicity Classification.
Frequency and clinical features of hearing loss caused by STRC deletions.
Diagnostic pitfalls for GJB2-related hearing loss: A novel deletion detected by Array-CGH analysis in a Japanese patient with congenital profound hearing loss.
Sensorineural hearing loss and mild cardiac phenotype caused by an EYA4 mutation.
Frequency of the STRC-CATSPER2 deletion in STRC-associated hearing loss patients.
Variants in CDH23 cause a broad spectrum of hearing loss: from non-syndromic to syndromic hearing loss as well as from congenital to age-related hearing loss.
Genetic background in late-onset sensorineural hearing loss patients.
The genetic etiology of hearing loss in Japan revealed by the social health insurance-based genetic testing of 10K.
Detailed clinical features and genotype-phenotype correlation in an OTOF-related hearing loss cohort in Japan.
Prevalence and clinical features of autosomal dominant and recessive TMC1-associated hearing loss.
Human deafness-associated variants alter the dynamics of key molecules in hair cell stereocilia F-actin cores.
Identification of a Novel Copy Number Variation of EYA4 Causing Autosomal Dominant Non-syndromic Hearing Loss.
Novel ACTG1 mutations in patients identified by massively parallel DNA sequencing cause progressive hearing loss.
Clinical Characteristics and In Vitro Analysis of MYO6 Variants Causing Late-Onset Progressive Hearing Loss.
Prevalence and clinical features of hearing loss caused by EYA4 variants.
Cochlear Implantation From the Perspective of Genetic Background.

Controlled access users

Principal investigatorAffiliationCountry/RegionResearch titlePeriod of data useDataset ID
Satoshi YuharaSRL inc./ H.U. Group Research Institute G.K.JapanValidation of Rare Disease Clinical Reporting System2024-07-01 – 2026-07-01